EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study

Florian Veyre, Claire Francoz iD, Domitille Erard, Eleonora DeMartin, Laure Elkrief, Camille Besch, Olivier Boillot iD, Filomena Conti, Sébastien Dharancy, Christophe Duvoux, Jean Gugenheim, Jean Hardwigsen und 24 weitere

Liver International · 2026

DOI: 10.1111/liv.70557 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Liver International, 2026. Verfasst von Florian Veyre und 35 weiteren Autor:innen. Beteiligte Einrichtung: Service D'hépato-Gastroentérologie, Centre de Référence Des Maladies Inflammatoires Des Voies Biliaires et Des hépatites Autoimmunes-Filière FILFOIE,…. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Liver Transplantation, Graft Survival. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A significant proportion of patients presenting a primary sclerosing cholangitis (PSC) will require liver transplantation (LT). The present study aimed to investigate graft loss and patient death in a large cohort of patients.

Methods

We conducted a nationwide multicenter retrospective study including all adult patients transplanted for PSC in France From 1985 to 2019.

Results

Were included 571 patients; median follow‐up after LT was 89.0 months (IQR, 43.0–151.0). Patient survival at 5, 10 and 20 years after LT was 88.2%, 81.2% and 62.6%. After exclusion of patients who died during the first month after LT, 37 patients (6.6%) died during the first 2 years and the main cause was malignancies ( n = 15, 40.5%, including 12 cases of recurrent cholangiocellular carcinoma). After 2 years, 90 patients (17.2%) died; the two main causes were malignancies ( n = 36, 40.0%, including 13 cases of colorectal cancer) and sepsis ( n = 23, 25.6%, of which 7 were related to recurrent PSC). Graft survival at 5, 10 and 20 years was 89.5%,78.7% and 62.7%. Independent factors associated with late patient death (after 2 years) were an older age at LT, a bilio‐digestive anastomosis and the use of preventive UDCA; independent factors associated with late graft loss were recurrent PSC, cellular rejection, a younger age at LT, and the use of tacrolimus (protective).

Conclusions

Our results emphasise that the prognosis after LT for PSC could be improved by better detection of cholangiocellular carcinoma before LT, and colorectal cancer after LT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangitis, SclerosingLiver TransplantationGraft SurvivalHumansFranceFemaleRetrospective StudiesMaleMiddle AgedAdult

Autor:innen und Institutionen

  • Service D'hépato-Gastroentérologie, Centre de Référence Des Maladies Inflammatoires Des Voies Biliaires et Des hépatites Autoimmunes-Filière FILFOIE, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.
  • Université Claude-Bernard Lyon 1, Lyon, France.
  • Service D'Hépatologie et Transplantation Hépatique, Hôpital Beaujon, APHP, Clichy, France.
  • Centre Hépato-Biliaire, Hôpital Paul Brousse, AP-HP, Université Paris Saclay, Unité Inserm, Villejuif, France.
  • Service D'Hépato-Gastroentérologie, Centre de Référence Des Maladies Vasculaires du Foie, Hôpital Trousseau, CHU Tours, Tours, France.
  • Service de Chirurgie Hépato-Bilio-Pancréatique et Transplantation Hépatique, CHRU Hautepierre, Strasbourg, France.

ORCID-Profile: Claire Francoz, Olivier Boillot, Nassim Kamar, François Durand, Audrey Coilly, Faouzi Saliba, Jérôme Dumortier

Zitieren

APA

Veyre, F., Francoz, C., Erard, D., DeMartin, E., Elkrief, L., Besch, C., Boillot, O., Conti, F., Dharancy, S., Duvoux, C., Gugenheim, J., Hardwigsen, J., Hilleret, M. N., Leroy, V., Ollivier-Hourmand, I., Gratien, M., Houssel-Debry, P., Kamar, N., Roux, O., …, & Dumortier, J. (2026). Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study. Liver International. https://doi.org/10.1111/liv.70557

Vancouver

Veyre F, Francoz C, Erard D, DeMartin E, Elkrief L, Besch C, et al. Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study. Liver International. 2026. doi:10.1111/liv.70557

BibTeX
@article{Veyre2026,
  author = {Veyre, Florian and Francoz, Claire and Erard, Domitille and DeMartin, Eleonora and Elkrief, Laure and Besch, Camille and Boillot, Olivier and Conti, Filomena and Dharancy, Sébastien and Duvoux, Christophe and Gugenheim, Jean and Hardwigsen, Jean and Hilleret, Marie-Noëlle and Leroy, Vincent and Ollivier-Hourmand, Isabelle and Gratien, Marilyne and Houssel-Debry, Pauline and Kamar, Nassim and Roux, Olivier and Hiriart, Jean-Baptiste and Irles-Depe, Marie and Pellegrin, Sophie and Durand, François and Pageaux, Georges-Philippe and Faure, Stéphanie and Coilly, Audrey and Radenne, Sylvie and Saliba, Faouzi and Samuel, Didier and Vanlemmens, Claire and Latournerie, Marianne and Boudjema, Karim and Salamé, Ephrem and Chazouillères, Olivier and Corpechot, Christophe and Dumortier, Jérôme},
  title = {Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study},
  journal = {Liver International},
  year = {2026},
  doi = {10.1111/liv.70557}
}
Kostenlos starten →